Psychiatry

Greater reductions in brain glycolysis demonstrated a relationship to symptoms of Alzheimer’s disease like memory problems.

In all cases of participants experiencing housing problems for even 1 year, indicated poorer mental health.

Two phase 3 clinical trials begin enrollment for treatment of manic episodes associated with bipolar I disorder.

Positive results showed 6 weeks of treatment associated with significant improvement of depressive symptoms in children and adolescents.

ARISTADA is being investigated as a possible extended-release injectable suspension, as well as INVEGA SUSTENNA in patients with acute exacerbation of schizophrenia.

Socioeconomic factors may play the largest role in increased suicide rates as they vary by urbanization level.

Evening-dosed psychostimulant is the first long-acting MPH single-dose formulation to show improvements in at-home early morning functional impairment.

The drug is being tested for the first time on a large scale adult patient population.

In response to patient concerns about dosing options and duration of effect, researchers at Shire Pharmaceuticals created Mydayis for the treatment of ADHD symptoms.

Alnylam Therapeutics expects to file for a New Drug Application in late 2017.

Psychedelics like psilocybin have been receiving attention from psychiatrists on and off for decades. Here's what we've learned, and what's on the horizon.

Parental rejection, abandonment, physical and sexual abuse double the victim's rates of depression, inflammation, metabolic disorders and chronic medical illnesses.

Patients struggling with addiction can be difficult to treat. Following best practices can help simplify a complex process.

The drug showed improved symptoms across multiple doses in a 6-month study.

Doris Greenberg, MD, discusses the fine line between Asperger's Syndrome and Autism Spectrum Disorder.

The treatment is a once-daily, extended-release liquid medication, but does not require refrigeration or pharmacy reconstitution.

The study authors theorized that there are further connections between age and HA, with older adults having significantly more HA than younger adults.

Using 24-hour wrist monitors, the study revealed “distinct mood-dependent effects on wrist-activity markers of circadian timekeeping.”

Cleveland Clinic physicians weigh in on their best methods for maintaining a good doctor-patient relationship.

These tools can reduce selection bias and misdiagnosis, and improve communication between primary and secondary care physicians.

12% of patients prescribed the 2 drugs in combination were still taking benzodiazepine 6 months later.

Their doubts may negatively affect their interest in creating teams of specialized physicians to help those patients.

Though safer for relapsing-remmitting multiple sclerosis than new disease-modifying therapies, the treatment nearly doubles the chance of a patient suffering from a stroke.

MS patients were significantly outscored by a control group in a series of social interaction tests.

Two blood proteins have shown a combined 82% accuracy in diagnosing ASD in a group of pediatric patients.